|The GLDN gldn (Catalog #MBS9222671) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The GLDN gldn product has the following accession number(s) (GI #74749534) (NCBI Accession #Q6ZMI3.1) (Uniprot Accession #Q6ZMI3). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Plays a role in the formation of the nodes of Ranvier along myelinated axons. Probable NRCAM and NFASC/neurofascin ligand which may provide a glial positional clue required for the proper molecular assembly of the nodes of Ranvier (By similarity).
Cellular Location: Cell membrane; Single-pass type II membrane protein. Note: Localizes to the nodes of Ranvier. Tissue Location: Specifically expressed in spinal cord, brain, placenta and sciatic nerve. More abundant in peripheral than central nervous system. Carcinoma, Carcinoma in Situ, Carcinoma, Hepatocellular, Immune System Diseases, Liver Diseases, Liver Neoplasms are some of the diseases may be linked to GLDN Antibody (Center) Blocking Peptide. Brain, Placenta, Testis tissues are correlated with this protein.